Back
ESC Premium Access

Differentiation of iPS-derived cardiac mesoderm cells into cardiomyocytes using inducible shRNA technology

Session: Poster Session 3 - IPS disease modelling and congenital heart disease
Topic: Gene Therapy, Cell Therapy
Speaker: Ms A. Garcia Duran (Berlin, DE)
Event: ESC Congress 2019

Congress Presentation

Add to my library

Like

About the speaker

Ms Ana Garcia Duran

Berlin (Germany)
0 follower

10 more presentations in this session

Self-adhesive bi-layered dressing incorporating amnion-derived mesenchymal stromal cells for the treatment of heart failure: a pre-clinical proof of concept study

Speaker: Doctor K. Kobayashi (London, GB)

Access
Abstract
Slides
Like
Thumbnail

Synergistic activation of the cardiac enhancer landscape during reprogramming

Speaker: Assistant Professor H. Hashimoto (Tokyo, JP)

Access
Abstract
Like
Thumbnail

Human iPSC-derived cardiomyocytes preserve murine heart function after myocardial infarction unlike adipose tissue-derived stromal cells

Speaker: Professor J. Dulak (Krakow, PL)

Access
Abstract
Like
Thumbnail

Modelling the duchenne muscular dystrophy-induced dilated cardiomyopathy using patient-specific induced pluripotent stem cells-derived cardiomyocytes.

Access
Like
Thumbnail

Sexual activity and dysfunction in adult patients with congenital heart disease

Speaker: Professor G. Diller (Muenster, DE)

Access
Abstract
Like
Thumbnail

Access the full session

Poster Session 3 - IPS disease modelling and congenital heart disease

Speakers: Ms A. Garcia Duran, Doctor K. Kobayashi, Assistant Professor H. Hashimoto, Professor J. Dulak, Professor G. Diller
Access
Like
Thumbnail

About the event

Image

ESC Congress 2019

31 August - 4 September 2019

Sessions Presentations

Congress
logo Image

ESC 365 is supported by

logo Bristol Myers Squibb Explore sponsored resources
logo Novo Nordisk Explore sponsored resources